BY NATHANIEL WEIXEL – 06/07/22 An outside advisory panel voted overwhelmingly to recommend that the Food and Drug Administration (FDA) authorize a COVID-19 vaccine made by Novavax for use in adults, a move that could lead to the addition of a fourth vaccine to the U.S. arsenal. The FDA’s vaccine advisory panel voted 21-0, with one abstention. The FDA does not have to follow the panel’s recommendation, though it often does.… Read the rest